Answer
Apr 01, 2026 - 10:18 AM
Current clinical trials suggest that retatrutide may lead to greater weight loss compared to semaglutide in people with obesity, with some studies showing higher average percentage weight reductions. However, retatrutide is still under investigation and not yet widely approved, so direct, long-term comparisons and safety data are still limited.
